Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Low-density lipoprotein receptor family** (often called apoE receptors) is a group of structurally related cell-surface receptors that bind apolipoprotein E (ApoE) and mediate endocytosis of various lipoprotein particles[5][3][7]. The most prominent member, the LDL receptor (LDLR), is critical for the clearance of cholesterol-rich lipoproteins in the liver and other tissues[5]. Family members, such as LDLR, LRP1 (low-density lipoprotein receptor-related protein 1), VLDLR (very-low-density lipoprotein receptor), and ApoER2 (LRP8), share structural motifs and overlapping ligand preferences[5]. ApoE-containing lipoproteins bind these receptors, which triggers endocytosis and delivery of lipids to cells, particularly hepatocytes and neurons[3][5][7]. In the central nervous system, these receptors are crucial for cholesterol transport from astrocytes to neurons, influencing synaptic function, neurodevelopment, and risk of neurodegenerative diseases such as Alzheimer’s disease[5][2][3]. Genetic variants or mutations affecting ApoE or its receptors can lead to lipid metabolism disorders, including familial hypercholesterolemia and type III hyperlipoproteinemia[3]. Receptor function is also involved in cardiovascular risk, and is a major target (directly or indirectly) of common lipid-lowering strategies such as statins and PCSK9 inhibitors. Ongoing research implicates these receptors in additional biological processes, such as immune regulation and brain repair mechanisms[5][7].
Promote hepatic uptake of ApoE-containing lipoproteins by endocytosis - Modulation of receptor-ligand interactions for cholesterol clearance - Intracellular signaling affecting lipid and neuronal homeostasis- Some drugs increase receptor expression or function (e.g., statins, PCSK9 inhibitors), enhancing lipoprotein clearance
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Low-density lipoprotein receptor family (LDLR family).